Astellas Pharma Inc (ALPMY)
10.70
0.00 (0.00%)
USD |
OTCM |
Nov 15, 16:00
Astellas Pharma Max Drawdown (5Y): 44.10% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 44.10% |
| September 30, 2024 | 44.10% |
| August 31, 2024 | 44.10% |
| July 31, 2024 | 44.10% |
| June 30, 2024 | 44.10% |
| May 31, 2024 | 44.10% |
| April 30, 2024 | 44.10% |
| March 31, 2024 | 37.25% |
| February 29, 2024 | 36.60% |
| January 31, 2024 | 32.88% |
| December 31, 2023 | 32.88% |
| November 30, 2023 | 31.64% |
| October 31, 2023 | 28.74% |
| September 30, 2023 | 29.44% |
| August 31, 2023 | 29.44% |
| July 31, 2023 | 29.44% |
| June 30, 2023 | 29.44% |
| May 31, 2023 | 29.44% |
| April 30, 2023 | 29.44% |
| March 31, 2023 | 29.44% |
| February 28, 2023 | 29.44% |
| January 31, 2023 | 29.44% |
| December 31, 2022 | 66.86% |
| November 30, 2022 | 69.98% |
| October 31, 2022 | 71.66% |
| Date | Value |
|---|---|
| September 30, 2022 | 71.66% |
| August 31, 2022 | 71.66% |
| July 31, 2022 | 71.66% |
| June 30, 2022 | 71.66% |
| May 31, 2022 | 71.97% |
| April 30, 2022 | 73.08% |
| March 31, 2022 | 73.08% |
| February 28, 2022 | 73.08% |
| January 31, 2022 | 73.08% |
| December 31, 2021 | 73.08% |
| November 30, 2021 | 73.08% |
| October 31, 2021 | 73.08% |
| September 30, 2021 | 73.08% |
| August 31, 2021 | 73.08% |
| July 31, 2021 | 73.08% |
| June 30, 2021 | 73.08% |
| May 31, 2021 | 73.08% |
| April 30, 2021 | 73.08% |
| March 31, 2021 | 73.08% |
| February 28, 2021 | 73.08% |
| January 31, 2021 | 73.08% |
| December 31, 2020 | 73.08% |
| November 30, 2020 | 73.08% |
| October 31, 2020 | 73.08% |
| September 30, 2020 | 73.08% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
28.74%
Minimum
Oct 2023
73.08%
Maximum
Nov 2019
58.89%
Average
72.53%
Median
Max Drawdown (5Y) Benchmarks
| Pfizer Inc | 54.78% |
| Takeda Pharmaceutical Co Ltd | 54.24% |
| Nxera Pharma Co Ltd | 95.29% |
| PeptiDream Inc | 87.73% |
| Healios KK | -- |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -11.92 |
| Beta (5Y) | 0.3493 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 23.70% |
| Historical Sharpe Ratio (5Y) | -0.3128 |
| Historical Sortino (5Y) | -0.5804 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 10.41% |